As of April 2026 Innate Pharma has a market cap of S$0.16 Billion. This makes Innate Pharma the world's 9113th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Apr 24th, 2026 the market cap of Innate Pharma was reported to be: